Rolland, BSc (Honours with distinction) Molecular/Cell Biology
Co-founder and Chief Research Director
Precision Oncology expert Alex Rolland is the CEO and co-founder of Cancer Treatment Options and Management. As Chief Research Director, Alex conducts personalized research, facilitates tests, consults on treatment options, monitors treatment plans, and advocates directly for his clients. Alex is passionate about ensuring that anyone who receives a cancer diagnosis has access to the most effective, and least invasive, form of treatment possible.
Alex holds a BSc in Molecular/Cell Biology from the University of Victoria, and studied Medical Genetics at the renowned Terry Fox Laboratory in Vancouver (BC Cancer Agency). He’s used his expertise to consult oncologists at the Mayo Clinic and other leading cancer treatment centers.
With over a decade of experience researching, consulting, and advocating for cancer patients, Alex also works directly with the medical system to explore the newest optimal treatments for his clients. He’s an expert in discovering how to optimize your cancer treatment, and making this a reality for you.
Discover more about Alex, including his educational background and professional experience in the field of cancer research.
You’ll also learn what inspired him to leave the lab, as well as his coveted teaching role, and to dedicate his life to helping cancer patients gain rapid access to the most effective treatments for their cancer. Alex is committed to changing the face of cancer care in Canada and throughout the world. His goal is to ensure that the CTOAM approach to cancer care becomes the standard of care, everywhere.
Research scientist Noushin Moshgabadi loves helping connect people with better healthcare and cancer treatment through her work in medical science.
Originally from Iran, Noushin has been living in British Columbia, Canada, for more than 15 years where she has studied and worked in scientific research for more than a decade. She obtained her Bachelors of Science in Cell & Molecular Biology from Vancouver’s Simon Fraser University (SFU); and her Masters of Science in Genetics, as well as her secondary Masters of Science, from the University of British Columbia’s Medical Genetics department (UBC).
Noushin has worked as a research scientist at Public Health Agency of Canada (PHAC), UBC hospitals, the Vancouver Prostate Centre (VPC), and several Genetics and Molecular Biology laboratories at both Simon Fraser University and the University of British Columbia.
In addition to her passion for genetics, molecular biology, and scientific research, Noushin enjoys exploring Vancouver’s beautiful natural landscape and hanging out with friends and family. She loves outdoor activities and can often be found doing different outdoor sports, like skiing, hiking, biking, sailing, and jogging.
Noushin is excited to be a part of the CTOAM team and working with cutting-edge experts who are leading the way in cancer care. Her life goal is to help people through medical science – and she feels that CTOAM provides her with an opportunity to make this dream come true.
To speak with Noushin, please contact CTOAM.
With a passion for medical science and helping others, Elham has studied and worked in life science for more than a decade. Her specialty is in genetics, cell and molecular biology, and scientific research – and the practical application thereof.
She obtained her Bachelor of Science in Cell & Molecular Biology from Tehran’s Kharazmi University. For over five years, she worked as a technician and researcher at highly regarded medical research centers, including The National Institute of Biotechnology and Genetic Engineering.
Elham completed her Master of Molecular Biology and Genetic Engineering from University Putra Malaysia. After being admitted into the Ph.D. program for Experimental Medicine at the University of British Columbia in Vancouver, she contributed to multiple leading-edge projects. Her work has been in highly-ranked journals and conferences.
Since moving to Canada ten years ago, Elham has worked with numerous innovative teams in various Vancouver General Hospital centers, including Eye Care Center, BC Cancer Agency, and Blusson Spinal Cord Center (iCord).
When she’s not using her scientific expertise to help patients at CTOAM, Elham enjoys practicing modern painting calligraphy and spending time with her husband and daughter. She also loves taking advantage of the West Coast’s incredible nature and the many outdoor activities it offers: skiing, cycling and trail hiking are favorite pastimes.
Elham has a deep interest in research activities that improve human lives, particularly in finding a cure and treatment for conditions for which there is not yet effective intervention. She’s excited and proud to be a part of the CTOAM team and helping more patients access leading-edge cancer care.
To speak with Elham, please contact CTOAM.
Genomics Sequencing Specialist
Dr. Mikolaj Raszek joined the CTOAM team in 2018 as a genomics sequencing specialist and educational outreach coordinator. Dr. Raszek is the founder and general manager of Merogenomics Inc., a Canada-based company dedicated to helping individuals gain access to the best quality genome sequencing services.
As a genomics expert, Dr. Raszek has received his doctorate degree (PhD) in biochemistry, his Bachelors in genetics, and post-doctorate work in agricultural genomics. All studies were completed at the University of Alberta. In addition to his work with CTOAM, Dr. Raszek also works out of the United Health Centre’s medical clinic in Edmonton, Alberta.
At CTOAM, Dr. Raszek helps our clients and their family members to have a clear understanding of the causes of their cancer and, most importantly, how genetic testing and personalized research work to generate the most accurate diagnosis and the best treatment outcomes that medical science can provide. Dr. Raszek is proud to be working with the cancer experts at CTOAM. He is particularly thrilled to be able to use his expertise in genomics to help bring the most current advances in cancer care to the people who need it most.
To speak with Dr. Raszek about DNA sequencing for cancer diagnosis and treatment, please contact CTOAM today.
Get the latest advancements in cancer care delivered straight to your inbox each month!